BDBM387130 (3aR, 7aR)-(2-(2H-1,2,3-triazol-2-yl)phenyl)-1- (4-(2-hydroxypropan-2-yl)oxazolo-2- yl)hexahydro-1H-pyrrolo[2,3-c]pyridin-6(2H)- yl)methanone::US9938276, C2

SMILES CC(C)(O)c1coc(n1)N1CC[C@@H]2CCN(C[C@H]12)C(=O)c1ccccc1-n1nccn1

InChI Key InChIKey=XLDUFQNVNJWVNG-YJBOKZPZSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 387130   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387130((3aR, 7aR)-(2-(2H-1,2,3-triazol-2-yl)phenyl)-1- (4...)
Affinity DataIC50:  1.00E+4nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387130((3aR, 7aR)-(2-(2H-1,2,3-triazol-2-yl)phenyl)-1- (4...)
Affinity DataIC50:  342nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent